Erivedge - erivedge.com : Advanced Basal Cell Carcinoma Treatment

2.33 Rating by ClearWebStats

erivedge.com is 1 decade 2 years 9 months old. This website has a #5,288,011 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 4 out of 10. This domain is estimated value of $ 240.00 and has a daily earning of $ 1.00. While no active threats were reported recently by users, erivedge.com is SAFE to browse.

Updated 9 years 4 months ago

Get Custom Widget

Traffic Report of Erivedge

Daily Unique Visitors:	91
Daily Pageviews:	182

Estimated Valuation

Income Per Day:	$ 1.00
Estimated Worth:	$ 240.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	19

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Not Applicable
WOT Privacy:	Not Applicable
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	5,288,011
Domain Authority:	Not Applicable

Google Pagerank

PR 4 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is erivedge.com server located?

Hosted IP Address:

72.34.128.191

View other site hosted with erivedge.com

Hosted Country:

Location Latitude:

45.4207

Location Longitude:

-122.671

Social Engagement

Facebook Shares:	Not Applicable
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View erivedge.com homepage link analysis

Page Title of Erivedge

Advanced Basal Cell Carcinoma Treatment | Erivedge® (vismodegib) capsule

Meta Description of Erivedge

Discover Erivedge® (vismodegib) capsule, a prescription oral medication approved for advanced basal cell carcinoma treatment. Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation. Important Safety Information: What is the most important information I should know about Erivedge? Erivedge can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects. For females who can become pregnant, talk with your healthcare provider about the risks of Erivedge to your unborn child. Your healthcare provider should do a pregnancy test within 7 days before you start taking Erivedge to find out if you are pregnant. Avoid pregnancy by using highly effective birth control before starting Erivedge, and continue during treatment and for 7 months after your last dose. Tell your healthcare provider right away if you have unprotected sex or think that your birth control has failed. For males, always use a condom with a spermicide during sex with female partners while you are taking Erivedge and for 2 months after your last dose, even if you have had a vasectomy. Tell your healthcare provider right away if you or your female partner could be pregnant or thinks she is pregnant while you are taking Erivedge. Exposure to Erivedge during pregnancy: Pregnant women are encouraged to participate in a program that collects information about exposure and the effects on the mother and her unborn child by calling the Genentech Adverse Event Line at (888) 835-2555. What should I tell my healthcare provider before taking Erivedge? If you are pregnant or plan to become pregnant. If you are breast-feeding or plan to breast-feed. What should I avoid while taking Erivedge? Do not give blood or blood products during treatment with Erivedge and for 7 months after your last dose. What are the possible side effects of Erivedge? The most common side effects of Erivedge are: Muscle spasms, Hair loss, Change in how things taste or loss of taste, Weight loss, Tiredness, Nausea, Diarrhea, Decreased appetite, Constipation, Vomiting, Joint aches. These are not all of the possible side effects of Erivedge. For more information, ask your healthcare provider or pharmacist. Because everyone is different, it is not possible to predict what side effects any one person will have or how severe they may be. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the full Prescribing Information, including serious side effects, and the Medication Guide at www.erivedge.com.

Meta Tags of Erivedge

erivedge, vismodegib, hedgehog pathway inhibitor, advanced basal cell carcinoma

Website Inpage Analysis

H1 Headings:	2	H2 Headings:	4
H3 Headings:	1	H4 Headings:	2
H5 Headings:	2	H6 Headings:	13
Total IFRAMEs:	Not Applicable	Total Images:	10
Google Adsense:	Not Applicable	Google Analytics:	UA-37696723-2

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Fri, 21 Nov 2014 07:46:23 GMT
X-Powered-By: Servlet 2.5; JBoss-5.0/JBossWeb-2.1
Accept-Ranges: bytes
ETag: W/"28258-1416336822000"
Last-Modified: Tue, 18 Nov 2014 18:53:42 GMT
Content-Length: 28258
Keep-Alive: timeout=1, max=100
Connection: close
Content-Type: text/html; charset=UTF-8
Content-Language: en

Domain Information for erivedge.com

Domain Registrar:	SAFENAMES LTD
Registration Date:	2011-07-12 1 decade 2 years 9 months ago
Last Modified:	2013-12-23 1 decade 3 months 3 weeks ago
Expiration Date:	2015-07-12 8 years 9 months 1 week ago

Domain Nameserver Information

Host		IP Address	Country
hlrns1.roche.com		198.21.25.33	United States
ns1.roche.com		196.3.50.135	Switzerland

DNS Record Analysis

Host	Type	TTL	Extra
erivedge.com	A	3596	IP:72.34.128.191
erivedge.com	NS	21599	Target:hlrns1.roche.com
erivedge.com	NS	21599	Target:ns1.roche.com
erivedge.com	SOA	3599	MNAME:ns1.roche.com RNAME:global.hostmaster.roche.com Serial:2014080533 Refresh:10800 Retry:3600 Expire:604800